Luyan Pharma Co (002788.SZ) Stock Price

Luyan Pharma Co Price

CLOSED
9.75
​
Market closed

Revenue has compounded at 15.1% per year over the past 14 years to 21.25 B CNY. Earnings per share have grown at 11.2% per year over the last 14 years. Luyan Pharma Co's net margin stands at 1.3%, broadly stable from 1.7% several years earlier. Luyan Pharma Co currently offers a dividend yield of about 3.59%. The payout ratio is around 48% of earnings. The dividend has grown at 18.1% per year over the past 9 years.

Luyan Pharma Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Luyan Pharma Co business model & stock analysis

Luyan Pharma Co Ltd, headquartered in Xiamen, Fujian, operates in the Health Care sector, specializing in the wholesale, distribution, manufacturing, and retail of pharmaceuticals, medical equipment, and healthcare products. The company, listed on 18 February 2016, serves medical institutions across Fujian Province, employing 5,286 full-time staff to support its operations in the region.

Frequently asked questions about Luyan Pharma Co

Converted at the current exchange rate, the Luyan Pharma Co share trades at 1.30 EUR (9.75 CNY).

The revenue cannot currently be calculated for Luyan Pharma Co.

The profit cannot currently be calculated for Luyan Pharma Co.

The P/E ratio cannot be calculated for Luyan Pharma Co at the moment.

The P/S cannot be calculated for Luyan Pharma Co currently.

The Eulerpool Quality Score for Luyan Pharma Co is 7/10.

The ISIN of Luyan Pharma Co is CNE1000025W1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Luyan Pharma Co is 002788.SZ. The ticker symbol is used to trade Luyan Pharma Co shares on the stock exchange.

Fair ValueTerminal
9.07 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
4.02 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website luyan.com.cn
Country
Currency
CNY
Initial public offering
Feb 18, 2016
ISIN
CNE1000025W1
Cusip
Y5S4BA109
Market capitalization
3.79 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
5.86
P/B Ratio
1.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.73 %
Dividend
Dividend yield
3.59 %
Payout Ratio
47.79 %
Dividend growth Ø5Y
11.84 %
Dividend payments per year
1
Dividend paid since
10 years
Dividend not reduced since
10 years
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Nov 6, 2026, 2:18 AM

Luyan Pharma Co Peer Group

Luyan Pharma Co FIGI

002788:CH · BBG006G2PPG4002788:CS · BBG006G2PPP4